Related references
Note: Only part of the references are listed.International Variation in Prostate Cancer Incidence and Mortality Rates
Melissa M. Center et al.
EUROPEAN UROLOGY (2012)
429 PCR-based detection of circulating tumor cells in prostate cancer – preliminary experience
T. Todenhöfer et al.
EUROPEAN UROLOGY SUPPLEMENTS (2012)
Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system
E. Andreopoulou et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis
L. A. Devriese et al.
LUNG CANCER (2012)
Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients
Robert Koenigsberg et al.
ACTA ONCOLOGICA (2011)
Mechanisms of Tumour Cell Dissemination and Methods for Detection of Circulating Tumour Cells in Transitional Cell Carcinoma
D. Schilling et al.
AKTUELLE UROLOGIE (2011)
Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
Medha S. Darshan et al.
CANCER RESEARCH (2011)
Circulating Tumor Cells as Biomarkers in Prostate Cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2011)
Circulating Tumor Cells as a Predictive Biomarker in Patients With Hormone-sensitive Prostate Cancer
Oscar B. Goodman et al.
CLINICAL GENITOURINARY CANCER (2011)
TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate
Daniel C. Danila et al.
EUROPEAN UROLOGY (2011)
Steps in prostate cancer progression that lead to bone metastasis
Jung-Kang Jin et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Can We Stop Prostate Specific Antigen Testing 10 Years After Radical Prostatectomy?
Stacy Loeb et al.
JOURNAL OF UROLOGY (2011)
Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
Andrew J. Armstrong et al.
MOLECULAR CANCER RESEARCH (2011)
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Anna Bill-Axelson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEE™ platform
Julie Ann Mayer et al.
CANCER GENETICS (2011)
All circulating EpCAM+CK+CD45-objects predict overall survival in castration-resistant prostate cancer
F. A. W. Coumans et al.
ANNALS OF ONCOLOGY (2010)
Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies
Dalibor Antolovic et al.
BMC BIOTECHNOLOGY (2010)
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
Tanja Fehm et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts
B. G. Barwick et al.
BRITISH JOURNAL OF CANCER (2010)
Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells
Henry K. Lin et al.
CLINICAL CANCER RESEARCH (2010)
Detection of Androgen Receptor Mutations in Circulating Tumor Cells in Castration-Resistant Prostate Cancer
Yuqiu Jiang et al.
CLINICAL CHEMISTRY (2010)
Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel
M. H. Strijbos et al.
EUROPEAN JOURNAL OF CANCER (2010)
Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer
Daniel C. Danila et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Significant and Sustained Antitumor Activity in Post-Docetaxel, Castration-Resistant Prostate Cancer With the CYP17 Inhibitor Abiraterone Acetate
Alison H. M. Reid et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Epithelial-to-Mesenchymal Transitions and Circulating Tumor Cells
Arnaud Bonnomet et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody
Jason P. Gleghorn et al.
LAB ON A CHIP (2010)
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
Howard I. Scher et al.
LANCET (2010)
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Shannon L. Stott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Quantification of Tumor Cell Burden by Analysis of Single Cell Lymph Node Disaggregates in Metastatic Prostate Cancer
David Schilling et al.
PROSTATE (2010)
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
D. Hawksworth et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Circulating Tumor Cell Analysis: Technical and Statistical Considerations for Application to the Clinic
Alison L. Allan et al.
JOURNAL OF ONCOLOGY (2010)
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients withMetastaticBreast Colorectal and Prostate Cancer
M. Craig Miller et al.
JOURNAL OF ONCOLOGY (2010)
Identification of EpCAM as a Molecular Target of Prostate Cancer Stroma
Sumana Mukherjee et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
D. Olmos et al.
ANNALS OF ONCOLOGY (2009)
Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study
P. Eschwege et al.
BRITISH JOURNAL OF CANCER (2009)
Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors
Oscar B. Goodman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer
Pamela L. Paris et al.
CANCER LETTERS (2009)
Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard et al.
CANCER RESEARCH (2009)
Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence
Todd M. Morgan et al.
CLINICAL CANCER RESEARCH (2009)
Circulating Prostate Tumor Cells Detected by Reverse Transcription-PCR in Men with Localized or Castration-Refractory Prostate Cancer: Concordance with CellSearch Assay and Association with Bone Metastases and with Survival
Pauliina Helo et al.
CLINICAL CHEMISTRY (2009)
Perioperative Activation of Disseminated Tumor Cells in Bone Marrow of Patients With Prostate Cancer
Dorothea Weckermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection
Lili Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Prognostic Significance of Circulating Tumor Cells in Patients With Hormone Refractory Prostate Cancer
Takatsugu Okegawa et al.
JOURNAL OF UROLOGY (2009)
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I. Scher et al.
LANCET ONCOLOGY (2009)
Detection of Circulating Tumor Cells in Prostate Cancer Patients: Methodological Pitfalls and Clinical Relevance
Zacharoula Panteleakou et al.
MOLECULAR MEDICINE (2009)
Survival in Surgically Treated, Nodal Positive Prostate Cancer Patients Is Predicted by Histopathological Characteristics of the Primary Tumor and Its Lymph Node Metastases
Achim Fleischmann et al.
PROSTATE (2009)
Expression of urokinase-type plasminogen activator system in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy
Masafumi Kumano et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Recommendations for the reporting of prostate carcinoma
Jonathan I. Epstein et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Review: Biological relevance of disseminated tumor cells in cancer patients
Sabine Riethdorf et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands
Wei He et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Prognostic Significance of Disseminated Tumor Cells in the Bone Marrow of Prostate Cancer Patients Treated With Neoadjuvant Hormone Treatment
Jens Koellermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: Initial results in early prostate cancer
John W. Davis et al.
JOURNAL OF UROLOGY (2008)
Clinical significance of p53 alterations in surgically treated prostate cancers
Thorsten Schlomm et al.
MODERN PATHOLOGY (2008)
Disseminated Tumor Cells in Bone Marrow Following Definitive Radiotherapy for Intermediate or High-Risk Prostate Cancer
Arne Berg et al.
PROSTATE (2008)
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
Tanja Fehm et al.
BREAST CANCER RESEARCH (2008)
Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients
Glenn Deng et al.
BREAST CANCER RESEARCH (2008)
Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone
Baisakhi Saha et al.
PROSTATE (2008)
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath et al.
NATURE (2007)
A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer
Karsten Gravdal et al.
CLINICAL CANCER RESEARCH (2007)
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2007)
New experimental markers for early detection of high-risk prostate cancer: role of cell-cell adhesion and cell migration
A. J. M. Mol et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
Epithelial cell adhesion molecule - More than a carcinoma marker and adhesion molecule
Monika Trzpis et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 years
Martin Schostak et al.
BJU INTERNATIONAL (2007)
The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: A comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer
Jesco Pfitzenmaier et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2007)
Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin
C. C. Yates et al.
BRITISH JOURNAL OF CANCER (2007)
Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy
Arne Berg et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
The natural history of noncastrate metastatic prostate cancer after radical prostatectomy
Ofer Yossepowitch et al.
EUROPEAN UROLOGY (2007)
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer
David R. Shaffer et al.
CLINICAL CANCER RESEARCH (2007)
Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancer
Jorge A. Garcia et al.
BJU INTERNATIONAL (2007)
Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR
Hideaki Miyake et al.
CLINICAL CANCER RESEARCH (2007)
The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a dutch multicenter validation of the diagnostic performance
Martijn P. M. Q. van Gils et al.
CLINICAL CANCER RESEARCH (2007)
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer:: A validation study of the CellSearch system
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2007)
Detection and characterization of putative metastatic precursor cells in cancer patients
Catherine Alix-Panabieres et al.
CLINICAL CHEMISTRY (2007)
Detection of sentinel node micrometastasis by step section and immunohistochemistry in patients with prostate cancer
Mamoru Fukuda et al.
JOURNAL OF UROLOGY (2007)
The metastatic cascade in prostate cancer
Manit Arya et al.
SURGICAL ONCOLOGY-OXFORD (2006)
Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene
Hartmut Schmidt et al.
CANCER RESEARCH (2006)
Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment
Anna C. Ferrari et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Detection of occult lymph node metastases in locally advanced node-negative prostate cancer
Vincenzo Pagliarulo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Combined immunohistochemistry of β-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer -: art. no. 31
S Ikeda et al.
BMC CANCER (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Bi-directional interactions of prostate cancer cells and bone marrow endothelial cells in three-dimensional culture
JM Barrett et al.
PROSTATE (2005)
Circulating tumor cells predict survival in patients with metastatic prostate cancer
JG Moreno et al.
UROLOGY (2005)
Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease
BT Chen et al.
UROLOGY (2005)
Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer
U Woelfle et al.
CLINICAL CANCER RESEARCH (2004)
The molecular staging of prostate cancer
IG McIntyre et al.
BJU INTERNATIONAL (2004)
Molecular staging by RT-PCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer
C Mitsiades et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific RT-PCR assay for human glandular kallikrein
SF Shariat et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Molecular staging of prostatic cancer with RT-PCR assay for prostate-specific antigen in peripheral blood and lymph nodes:: Comparison with standard histological staging and immunohistochemical assessment of occult regional lymph node metastases
L Martínez-Piñeiro et al.
EUROPEAN UROLOGY (2003)
The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer
F Wawroschek et al.
EUROPEAN UROLOGY (2003)
Methylation-specific PCR for DNA-based detection of occult tumor cells in lymph nodes of prostate cancer patients
J Kollermann et al.
EUROPEAN UROLOGY (2003)
Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy
J Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Presence of circulating prostate cancer cells in African American males adversely affects survival
FJ Bianco et al.
UROLOGIC ONCOLOGY (2002)
Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer:: Detection and prognostic value
D Weckermann et al.
JOURNAL OF UROLOGY (2001)
Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer.: Comparison of CK19, MUC1 and CEA using RT-PCR
N Berois et al.
EUROPEAN JOURNAL OF CANCER (2000)
Isolation by size of epithelial tumor cells - A new method for the immunomorphological and molecular characterization of circulating tumor cells
G Vona et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
